Nucleus is redefining next-generation consumer genetic testing and analysis by building software for users to receive rare variant analysis and polygenic scores across various diseases and traits — ranging from breast cancer risk to longevity disposition. Individuals who have done microarray genetic testing from companies such as 23andMe can upload their genotyped DNA on the Nucleus platform to receive a subset of the possible genetic analyses, centering around polygenic scores. Our proprietary algorithms calculate these scores, which combine the effects of hundreds, thousands, or even millions of DNA letters that vary from individual to individual. A big part of Nucleus’ long-term mission is to ensure that the user’s overall experience from the reports is personalized by combining genetic and non-genetic data. This way, we can give them the most holistic picture of their health.
Nucleus’ mission is to empower people to take agency over their health so no one dies from preventable disease. That’s why the company is building a platform where everyone has their genome in their pocket, has complete clarity on their risks, and are empowered by personalized health measures. We are a growing company looking for skilled, committed, and passionate people to join our team. Our values are deeply rooted in providing a dynamic and diverse startup culture and experience.
Investors
We’ve raised over $15m from investors across
Benefits:
